Spark Investment Management LLC - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 21 filers reported holding RECRO PHARMA INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Spark Investment Management LLC ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2019$266,000
-63.0%
24,051
-66.0%
0.03%
-32.0%
Q2 2019$719,000
+215.4%
70,700
+81.6%
0.05%
+354.5%
Q1 2019$228,000
-24.5%
38,925
-8.6%
0.01%
-35.3%
Q3 2018$302,000
-49.1%
42,600
-64.0%
0.02%
-51.4%
Q2 2018$593,000
+111.0%
118,200
+270.5%
0.04%
+52.2%
Q3 2016$281,000
-9.1%
31,900
-18.0%
0.02%
-20.7%
Q2 2016$309,000
-21.6%
38,900
-41.1%
0.03%
-27.5%
Q1 2016$394,000
-35.4%
66,094
-2.5%
0.04%
-48.7%
Q4 2015$610,000
+6.8%
67,800
+42.4%
0.08%
+5.4%
Q3 2015$571,000
+151.5%
47,600
+170.5%
0.07%
+131.2%
Q2 2015$227,00017,6000.03%
Other shareholders
RECRO PHARMA INC shareholders Q1 2016
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders